| 1. A Case of Malignant Chondroid Syringoma with Lung Metastasis. |
Page:1119—1119 |
| 2. Primary Squamous Cell Carcinoma of the Breast. |
Page:1114—1118 |
| 3. A Clinical Study on Patients with Chronic Lymphocytic Leukemia. |
Page:1106—1113 |
| 4. Clinical Study of Stage I Renal Cell Carcinoma. |
Page:1100—1105 |
| 5. Transhiatal Esophagectomy Using Laparoscope in Esophageal Cancer. |
Page:1094—1099 |
| 6. Characteristics and Prognosis in Gastric Cancer with Liver Metastasis. |
Page:1085—1093 |
| 7. Clinicopathologic Features and Prognosis of Gastric Remnant Cancer after Partial Gastrectomy for Benign and Malignant Gastric Lesions. |
Page:1076—1084 |
| 8. Clinicopathologic Features, Survival Rates and Prognostic Factors of Gastric Cancer in Young Age Group under 30 Years of Age. |
Page:1069—1075 |
| 9. A Clinical Study of 500 Cases of Breast Cancer. |
Page:1061—1068 |
| 10. Results of Postoperative Radiation Therapy in 77 Patients of Breast Cancer. |
Page:1049—1060 |
| 11. Expression of Rous Sarcoma Virus Enhancer Factor Gene in Human Hepatocellular Carcinoma. |
Page:547—554 |
| 12. Post-operative Adjuvant Chemotherapy with 5-Fluorouracil, Leucovorin, and Mitomycin C (MLF) for Gastric Cancer. |
Page:791—799 |
| 13. Effects of Lovastatin in Combination with 5-FU on Stomach Cancer Cells. |
Page:785—790 |
| 14. The Expression of c-myc and AAT in Gastric Carcinoma. |
Page:774—784 |
| 15. Clinical Significance of Urokinase-type Plasminogen Activator (uPA) Expression from Serum and Tissue of Gastric Cancer Patients. |
Page:765—773 |
| 16. A Study of Retrovirus-mediated p53 Gene Transduction Into Human Gastric Cancer Cell Lines. |
Page:754—764 |
| 17. Reclassification of the Medullary Carcinoma and It's Clinical Characteristics. |
Page:748—753 |
| 18. The Significance of DNA Flow-cytometry in Breast Cancer. |
Page:738—747 |
| 19. Value of Phospholipase C gamma-1, Epidermal Growth Factor Receptor, and Her-2/neu in Human Breast Cancer. |
Page:724—737 |
| 20. Germline Mutations of BRCA1 Gene in Korean Breast and/or Ovarian Cancer Families. |
Page:713—723 |
| 21. Lumpectomy with Axillary Dissection for Breast Cancer. |
Page:1041—1048 |
| 22. Increment of Telomerase Activity with Breast Cancer Progression. |
Page:1032—1040 |
| 23. TGF-beta-1 Expression and p53 Mutation in Non-small Cell Carcinomas of the Lung. |
Page:1022—1031 |
| 24. Combination Chemotherapy with Etoposide, Ifosfamide, and Cisplatin (VIP) in Small Cell Lung Cancer. |
Page:1011—1021 |
| 25. Prognostic Factor Analysis of Small Cell Lung Cancer: Appropriateness of Two Staging System. |
Page:1000—1010 |
| 26. Linear Accelerator-Based Stereotactic Radiosurgery for Acoustic Neurinomas. |
Page:992—999 |
| 27. Prognostic Factors for Local Control and Survival in T1-T2 Glottic Cancer. |
Page:984—991 |
| 28. Differential Mucin Gene Expression Associated with Methotrexate Resistance of Human Colonic Adenocarcinoma Cell Line, HT29. |
Page:977—983 |
| 29. Effects of Lipid Soluble Components of Korean Red Ginseng on Proliferation and Cell Cycle Regulation Factors in Human Melanoma Cell Lines. |
Page:965—976 |
| 30. A Study on the Tropism of Epstein-Barr Virus. |
Page:954—964 |
| 31. Alteration of Oleate-Phospholipase D Activities in Some Cell Lines after Irradiation. |
Page:944—953 |
| 32. Characterization of Apoptotic Human Thymocytes. |
Page:930—943 |
| 33. The Relationship between Radiation-induced Apoptosis and the Expression of Cytokines in the Small Intestine of Rats. |
Page:921—929 |
| 34. Malignant Gastric Tumors Excluding Adenocarcinoma. |
Page:340—343 |
| 35. Comparison of Tropisetron with Ondansetron in the Prevention of Cisplatin-induced Nausea and Vomiting. |
Page:332—339 |
| 36. Combined Therapy of Gene Therapy using the Herpes Simplex Virus Thymidine Kinase, and Retinoic Acid. |
Page:321—331 |
| 37. Role of Cell Surface Mucin on Invasion and Metastasis of HM7 Colon Cancer Cells. |
Page:309—320 |
| 38. Cytogenetic Effects of Radiotherapy on Peripheral Blood Lymphocytes of Cancer Patients. |
Page:299—308 |
| 39. Germline Mutation of Rb1 Gene in Korean Retinoblastoma Patients. |
Page:291—298 |
| 40. A Study on the Loss of Heterozygosity of the p53 Gene in Primary Uterine Cervical Carcinomas. |
Page:280—290 |
| 41. Prognostic Significance of Histologic Features, DNA Content, Expression of Proliferating Cell Nuclear Antigen (PCNA), c-fos Protein and Transforming Growth Factor (TGF)-alpha and -beta in Giant Cell Tumor of Bone. |
Page:266—279 |
| 42. Quantitative Correlation between the Biochemical Markers and The Extent of Metastatic Bone Tumors. |
Page:257—265 |
| 43. Palliative Radiotherapy for Painful Bone Metastases. |
Page:250—256 |
| 44. Expression of DNA Topoisomerase II and P-Glycoprotein in Breast Cancer. |
Page:242—249 |
| 45. Efficiency of Positron Emission Tomography (PET) in Diagnosis of Breast Cancer. |
Page:235—242 |
| 46. Hepatic Intraarterial Chemotherapy in Unresectable Hepatic Metastases of Colorectal Cancer. |
Page:227—234 |
| 47. Studies on the Mechanism of Hypoxic Increase of VEGF Expression in the Hep3B Human Hepatoma Cells. |
Page:220—226 |
| 48. Detection of p53 Gene Mutations in Gastric Cancers: Comparative study of Single Strand Conformational polymorphism migration Technique (SSCP) and Non-Isotopic RNase Cleavage Assay (NIRCA). |
Page:212—219 |
| 49. Midkine Gene Expression in Gastric Cancer Tissues. |
Page:204—211 |
| 50. Prognostic Significance of the Extent of Lymph Node Dissection in Gastric Cancer. |
Page:198—203 |
| 51. Effects of Combination Chemotherapy Depending on The Expression of Neuron Specific Enolase (NSE), P-Glycoprotein (PgP) and Glutathione S-Transferase (GST)-pai in Advanced Non-Small Cell Lung Cancer. |
Page:189—197 |
| 52. A Case of Metastatic Epididymal and the Other Metastatic Testicular Carcinoma from Sigmoid Carcinoma. |
Page:706—706 |
| 53. Stability of Cisplatin and Etoposide in Normal Solution. |
Page:700—705 |
| 54. Effect of Granisetron Plus Dexamethasone in the Prevention of Delayed Nausea and Vomiting. |
Page:690—699 |
| 55. Type IV Collagen and E-cadherin Expression of Progressive Uterine Cervical Epithelial Lesions. |
Page:681—689 |
| 56. Glutathione S-Transferase Polymorphisms and Genetic Susceptibility to Cervical Cancer. |
Page:673—680 |
| 57. Pronostic Value of The Expression of Mutant p53 and EGFR mRNA in Transitional Cell Carcinoma of the Bladder. |
Page:663—672 |
| 58. The Detection of the Heat Production in Breast Cancer. |
Page:656—662 |
| 59. Effect of Paclitaxol, Cisplatin, and 5-Flurouracil Chemotherapy in Advanced Stomach Cancer. |
Page:648—655 |
| 60. Tumor Angiogenesis As a Predictor of Prognosis in Gastric Carcinoma. |
Page:640—647 |
| 61. Effects of Combined Splenectomy with Total Gastrectomy on the Prognosis in Gastric Cancer. |
Page:632—639 |
| 62. Using the Lymph Node Metastasis Prediction Program in Curative Resection of Gastric Cancer. |
Page:623—631 |
| 63. Comparison of Radiation Therapy and Combined Chemotherapy and Radiation Therapy for Locally Advanced Head and Neck Cancer. |
Page:616—622 |
| 64. Phase III Randomized Trial of ACNU in Addition to Surgery and Radiotherapy for Patients with Supratentorial Malignant Gliomas. |
Page:608—615 |
| 65. Study of UV DNA Repair Endonucleases with Respect to Skin Cancers. |
Page:599—607 |
| 66. p53 Gene Mutations in Astrtocytoma Detection by Direct DNA Sequencing. |
Page:590—598 |
| 67. Radiosensitivity in Acquired Cisplatin-Resistant Human Stomach Adenocarcinoma Cells. |
Page:584—589 |
| 68. The Effect of Metallothionein on the Resistance to Cisplatin in Transfected Mouse NIH/3T3 Cells. |
Page:576—583 |
| 69. Limited Cytotoxic Effect of Adenoviral-mediated p53 Gene Transfer in Variable Non-small Cell Lung Cancer (NSCLC) Cell Lines. |
Page:565—575 |
| 70. Effects of Interleukin-2 Transduction into the Human Hepatoma Cell Lines Using Retroviral Vector. |
Page:555—564 |
| 71. A Case of Cryptococcal Meningitis in a Brest Cancer Patient with Liver Metastasis, Suffering from Herpes Zoster. |
Page:540—540 |
| 72. A Case of Pyloric Obstruction Caused by Self-expandable Metallic Stent for Palliation of Malignant Dysphagia. |
Page:534—539 |
| 73. A Case of the Pancreatic Pseudocyst due to Metastatic Malignant Melanoma. |
Page:528—533 |
| 74. A Case of Ovarian Mullerian Mucinous Papillary Cystadenoma of Borderline Malignancy. |
Page:522—527 |
| 75. A Case of Acute Myelogenous Leukemia during Pregnancy. |
Page:516—521 |
| 76. Acute Myeloid Leukemia with Trisomy 9 Following Chemotherapy of Non-Hodgkin's Lymphoma. |
Page:512—515 |
| 77. The Study of Chromosomal Aberration in NSCLC Patients which Developed after Administration of Chemotherapeutic Agents. |
Page:504—511 |
| 78. Morphological Transformation Region II (mtrII) of Human Cytomegalovirus. |
Page:495—503 |
| 79. IMVP-16/Pd (Ifosfamide/Methotrexate/VP-16/Prednisone) Combination Chemotherapy for the Treatment of Relapsed or Refractory Non-Hodgkin's Lymphoma. |
Page:486—494 |
| 80. The Incidence of Epstein-Barr Virus Nuclear Antigen in Sporadic Non-Hodgkin's Lymphomas of Korean. |
Page:473—485 |
| 81. The Patterns of Lateral Neck Node Involvement in Papillary Thyroid Carcinoma. |
Page:466—472 |
| 82. An Immunohistochemical Study of Tumor Angiogenesity and EMA Reactivity in Papillary Thyroid Carcinoma. |
Page:454—465 |
| 83. Immunodetections of the Metalloproteinase (MMP-2 and MMP-9) and Tissue Inhibitor of Metalloproteinases (TIMP-2) in Prostatic Adenocarcinomas. |
Page:445—453 |
| 84. In Vitro Growth Inhibition of Human Ovarian Cancer Cell Lines by Mitosene Analogues. |
Page:437—444 |
| 85. Cytochrome P450 2E1 Polymorphisms and Genetic Susceptibility to Cervical Cancer. |
Page:429—436 |
| 86. A Clinicopathologic Analysis of Medullary Breast Cancer. |
Page:422—428 |
| 87. A Study of Apoptosis, and bcl-2 and p53 Expressions in Breast Cancer. |
Page:412—421 |
| 88. A Case of Malignant Mesothelioma of the Uterus. |
Page:362—362 |
| 89. Chronic Subdural Hematoma Associated with Dural Metastasis of Gastric Carcinoma. |
Page:358—361 |
| 90. A Case of Primary Splenic Angiosarcoma Associated with Kasabach-Merritt Syndrome. |
Page:352—357 |
| 91. Avascular Necrosis of Bone Complicating Treatment of Malignant Lymphoma: Report of 6 cases. |
Page:344—351 |
| 92. A Case of Solitary Bone Plasmacytoma of the Middle Cranial Fossa. |
Page:182—182 |
| 93. A Case of Cervical Adenocarcinoma with Pulmonary Metastasis Resembling Miliary Tuberculosis. |
Page:176—181 |
| 94. A Case of Head and Neck Cancer Diagnosed In a Systemic Lupus Erythematosus Patient. |
Page:171—175 |
| 95. Clinicopathological Correlation of Bcl-2 and p53 Immunohistochemistry in Breast Cancer. |
Page:404—411 |
| 96. Anti-tumor Effects of Growth Factor Inhibitors and Anti-metastatic Agents in Human Gastric Cancer Cell Lines. |
Page:391—403 |
| 97. Immunoregulatory Effect of Mesima (R) as an Immunotherapeutic Agent in Stage III Gastric Cancer Patients after Radical Gastrectomy. |
Page:383—390 |
| 98. Polymorphism Analysis of Helicobacter pylori Urease A Gene in Gastric Cancer Samples. |
Page:375—382 |
| 99. Significant Correlation of Hepatocyte Growth Factor Level with Progression of Gastric Adenocarcinoma. |
Page:367—374 |
| 100. Effect of Cytosine Arabinoside and Daunorubicin (AD) Combination Chemotherapy in Acute Myelogenous Leukemia. |
Page:160—170 |
| 101. VACOP-B (Etoposide/Doxorubicin/Cyclophosphamide/Vincristine/Prednisolone/Bleomycin) Combination Chemotherapy for the Treatment of Intermediate and High Grade Non-Hodgkin's Lymphoma. |
Page:146—159 |
| 102. Clinicopathologic Comparison of Intermediate or High Grade Peripheral T-Cell Lymphoma with Diffuse B-Cell Lymphoma. |
Page:136—145 |
| 103. Chemotherapy of Advanced Soft Tissue Sarcoma with Etoposide, Ifosfamide, and Cisplatin (VIP). |
Page:128—135 |
| 104. Expression of Gonadotropin-Releasing Hormone Receptor in Human Uterine Endometrial and Ovarian Tissues. |
Page:117—127 |
| 105. The Results of Postoperative Radiation Therapy in the Rectal Cancer. |
Page:111—116 |
| 106. A Phase II Study of AP (Doxorubicin, Cisplatin) Chemotherapy in Patients with Advanced Hepatocellular Carcinoma. |
Page:103—110 |
| 107. Immunohistochemical Analysis of the Expression of Cathepsin D in Human Gastric Adenocarninoma. |
Page:93—102 |
| 108. Synchronous Expression of Circulating Intercellular Adhesion Molecule-1 (ICAM-1) and Vascular Cell Adhesion Molecule-1 (VCAM-1) During Gastric Cancer Progression. |
Page:81—92 |
| 109. Evaluation of Biologic Phenotype by Midkine Gene Expression in Gastric Cancer as a Target for Biotherapy. |
Page:69—80 |
| 110. Quantitative Analysis of Metastatic Lymph Nodes after Curative Surgery in Gastric Cancer. |
Page:62—68 |
| 111. Relation Between Hormone Receptor (Enzyme-Immunoassay and Immunohistochemistry), Histologic Grade and Mammographic Findings in Patients with Primary Breast Cancer. |
Page:53—61 |
| 112. 5-Fluorouracil, Leucovorin, Ifosfamide and Cisplatin (FLIP) Combination Chemotherapy for Adevanced Non-Small Cell Lung Cancer. |
Page:46—52 |
| 113. Effect of FCL (5-FU, carboplatin, leucovorin) Chemotherapy in Advanced Head and Neck Cancer. |
Page:38—45 |
| 114. Anti-tumor Effect of the Complex of Acriflavine and Guanosine (AG60). |
Page:29—37 |
| 115. Antitumor Effect of Methotrexate in SCID Mice with Human Leukemia CCRF-CEM Cell Line. |
Page:19—28 |
| 116. Expression and Intracellular Localization of Hepatitis C Viral Core Protein in Human Hepatoma Cell Line Transfected with Viral cDNA. |
Page:11—18 |
| 117. Comparison of Efficiency of Infection of Human Cancer Cell Lines Via Retroviral Vector System. |
Page:1—10 |
| 118. A Report of Hepatocellular Carcinoma with Renal Metastasis. |
Page:914—914 |
| 119. Four Cases of Typhlitis, Developed in Neutropenic State and Treated with Medical Conservative Management. |
Page:906—913 |
| 120. A Clinical Analysis of Primary Small Bowel Cancer. |
Page:899—905 |
| 121. A Phase I/II Trial of DA3030 in Chemotherapy Induced Neutropenia. |
Page:886—898 |
| 122. A Preliminary Report of Busulfan, Melphalan and Thiotepa or TBI-containing Bi-alkylator Chemotherapy as a Preparative Regimen for Allogeneic Bone Marrow Transplantation in Refractory or Relapsed Acute Leukemias. |
Page:874—885 |
| 123. Immunohistochemical Study on Expression of the p53 Protein in Medulloblastoma/PNET. |
Page:867—873 |
| 124. Significance of Epstein-Barr Virus Detection in non-Hodgkin's Lymphoma in Korea. |
Page:851—866 |
| 125. Evaluation of Staging with MR Imaging in the Uterine Cervical Cancer. |
Page:842—850 |
| 126. The Results of Radiation Therapy in Patients with Cancer of the Esophagus. |
Page:832—841 |
| 127. Age-related Clinical Characteristics and Outcome of Hepatic Resection Therapy in Hepatocellular Carcinoma Patients. |
Page:825—831 |
| 128. Evaulation of Angiogenesis and Matrix Metalloproteinase as Prognostic Markers in Squamous Cell Carcinoma of the Lung. |
Page:816—824 |
| 129. The Effect of Neoadjuvant Chemotherapy with 5-Fluorouracil (5-FU), Vinblastine and Cisplatin (FVP) for Stage III Non-Small Cell Lung Cancer (NSCLC). |
Page:807—815 |
| 130. The Effects of Mesima-Ex, the Immunomodulator in Curatively Resected Gastric Cancer. |
Page:800—806 |
